Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 Funding-lir 5 Industry Buzz: Provista Teams With Lpath to Improve Ovarian Cancer Tests

Industry Buzz: Provista Teams With Lpath to Improve Ovarian Cancer Tests

Provista Diagnostics has entered into an agreement with Lpath to create new laboratory tests targeting significant gaps in early ovarian cancer detection. The Scottsdale, Ariz.-based Provista, which focuses on molecular-based cancer diagnostic testing, said the parties would focus their collaboration on a bioactive known as lipid lysophosphatidic acid, or LPA, which can be an indicator […]

Provista Diagnostics has entered into an agreement with Lpath to create new laboratory tests targeting significant gaps in early ovarian cancer detection. The Scottsdale, Ariz.-based Provista, which focuses on molecular-based cancer diagnostic testing, said the parties would focus their collaboration on a bioactive known as lipid lysophosphatidic acid, or LPA, which can be an indicator…

This content is for Paid Members only.
Login Register